Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check6 days agoChange DetectedThe page now includes a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The previous version displayed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays a new revision line 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'; no other content appears to be affected.SummaryDifference0.0%

- Check42 days agoChange DetectedExpanded the Study Locations section to include numerous US states and international sites (e.g., Fukuoka, Kanagawa, Nara, Tokyo) and updated the revision to v3.3.3.SummaryDifference1%

- Check71 days agoChange DetectedPublications sourcing note updated: it now states that publications are automatically filled in from PubMed and may not all be about the study, replacing the previous wording that said publications come from PubMed and are automatically created by ClinicalTrials.gov using the NCT number; Revision changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoved the government funding and operating status notice from the page; no trial data or essential study details were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now includes a Results section with results posted (Results First Posted 2022-09-09) and related publications. This provides access to outcomes data.SummaryDifference0.2%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.